RE:RE:RE:As we approach February 11thPablo.
The share issue is what killed us the last time back in 2018. That issue came in spring 2018. By fall of 2018 the shorting started. Look, they have some cash to cover some
extra interest payments for the next couple of years, and can bring down the maturing debt in the next couple of years. Hope EBIT of BA can cover 3/4 of the extra interest payment carried in 2020/21. Worse come to worse we could be out about $500 mill in extra interest interest payment for the next 2 years. Hopefully they'll be able to get better margins from BA to deal with the extra interest. But they'll to be able to find a way to deal with this JBD. I think refinancing early is good. But there will be discharge payments. Maybe they can roll the discharge penalties in the new refinanced debt to discharge old debt.. Why is diluting the shareholder the way to go in your mind. Why not the traditional road of prudent economics by the firm.
They need help with Financial Planing. Not dilution or privatization. They know how to scam the shareholder well. They don't need tips from us.
PabloLafortune wrote: We don't know how BA generated the $375M (200M+interest+prefs) in Q4 - could be increased backlog, could be high EBIT, could be something else that came thru on the balance sheet (reduced inventory) or a combination. In any event, its my opinion that the best catalyst for the share price atm is a big convertible share issue eg $1.8B USD @2.5% with a US$1 conversion price (a premium on the As). Because if they don't get the debt down, company is still very much at risk medium term - investors probably don't realize I'm sure that in addition to the 4.7B debt, the "other" liabilities net of other assets will probably still be a big # ($800M?) and there is a lot of backlog/customer deposits on the balance sheet that is not current which with every quarter some of it moves to current and some current moves off the balance sheet as sales are generated and gets replaced with new orders (sorry for the runon sentence).